AMI: anaemia at admission linked to increased mortality risk

  • Colombo MG & al.
  • BMC Cardiovasc Disord
  • 9 Mar 2018

  • from Sarfaroj Khan
  • Clinical Summaries
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • In patients with acute myocardial infarction (AMI), both mild and moderate to severe anaemia at admission was found to be significantly associated with increased all-cause mortality risk.

Why this matters

  • Severe anaemia is a common condition seen in hospitalised patients and has been identified as a predictor of adverse outcomes.

Study design

  • Prospective study of 2011 patients hospitalised for AMI selected from the MONICA/KORA myocardial infarction registry between January 2005 and December 2008.
  • Patients’ Hb levels were assessed at admission, and they were followed up until December 2011.
  • Funding: German Federal Ministry of Health.

Key results

  • Overall, 283 patients were reported to be anaemic (mild, n=183; moderate to severe, n=100) and 1728 patients did not have anaemia.
  • During the median follow-up period of 4.2 years, mortality was seen in 241 patients (12%).
  • Patients in the moderate to severe anaemia group had a higher incidence of mortality (n=37; 37%) vs patients in the mild anaemia group (n=48; 26.2%).
  • Mortality risk was significantly higher in patients with moderate to severe anaemia (HR, 2.05; 95% CI, 1.37-3.05) as well as mild anaemia (HR, 1.74; 95% CI, 1.23-2.45) vs patients without anaemia.

Limitations

  • Data on cancer or other chronic diseases which could affect post-AMI survival was unavailable.
  • Risk for bias.